Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options.
about
Topical alprostadil treatment of female sexual arousal disorder.UK-414,495, a selective inhibitor of neutral endopeptidase, potentiates pelvic nerve-stimulated increases in female genital blood flow in the anaesthetized rabbitThe making of a disease: female sexual dysfunction.Internal pudendal artery from type 2 diabetic female rats demonstrate elevated endothelin-1-mediated constriction.Novel approaches to female sexual dysfunction.Effects of adenosine monophosphate used in combination with L-arginine on female rabbit corpus cavernosum tissueEndothelin-1 induces contraction of female rat internal pudendal and clitoral arteries through ET(A) receptor and rho-kinase activation.Sexual function, delivery mode history, pelvic floor muscle exercises and incontinence: a cross-sectional study six years post-partum.Treatment of female sexual dysfunction.Genetic influences on variation in female orgasmic function: a twin studyLate-stage clinical development in lower urogenital targets: sexual dysfunction.Characterization of the vasculature supplying the genital tissues in female rats.Intersex surgery in the adult.Systematic review and meta-analysis of phosphodiesterase type 5 inhibitors for the treatment of female sexual dysfunction.Progress in female sexual dysfunction.Prevalence and pattern of sexual dysfunction in married females receiving antidepressants: An exploratory studyContested psychiatric ontology and feminist critique: 'Female Sexual Dysfunction' and the Diagnostic and Statistical Manual.Assessing the clinical efficacy of sildenafil for the treatment of female sexual dysfunction.Testosterone supplementation for hypoactive sexual desire disorder in women.Urinary disorders and female sexual function.An update on sexual function and dysfunction in women.Prevalence and factors associated with sexual dysfunction among HIV-positive women in Europe.Non-alcoholic fatty liver disease as a risk factor for female sexual dysfunction in premenopausal women.Decreased testosterone in regularly menstruating women with decreased libido: a clinical observation.Evidence for centrally initiated genital vasocongestive engorgement in the female rat: findings from a new model of female sexual arousal response.Efficacy and safety of topical alprostadil cream for the treatment of female sexual arousal disorder (FSAD): a double-blind, multicenter, randomized, and placebo-controlled clinical trial.The prevalence and clinical relevance of sexual dysfunction in women and men with chronic heart failure.MRI of female genital and pelvic organs during sexual arousal.The effect of migraine and tension-type headaches on female sexual functions: A prospective, cross-sectional, controlled study
P2860
Q33245951-0306A531-4484-40E7-B270-6E1D2657802EQ33562020-8F2E2DC0-5263-4216-9A40-C26560DFE832Q33813396-B90C7941-C6A6-4ED4-95C9-74CC9AE8D385Q34073718-014CDC21-FF4E-4535-B867-23524EFF8F04Q34104594-F19D4945-9526-45E3-B2EA-EADC42A748B0Q34286586-3343B64F-1FA6-4CB0-AEDC-FF485199A4CDQ34700728-AB3A6F93-0607-4FD3-BFAB-9B5A8036EF29Q34784935-9B41AF81-93CE-43E2-98C8-48C03DC9685CQ35092955-FC11C4DF-73BC-45FD-9A4B-3C3D3B97D410Q35101173-176E6831-F312-4C6C-85EC-2626D3594494Q35545741-A5D6D516-4151-4DD5-BAC9-834651B63440Q35659105-F408B12C-99AA-4051-BA89-FEF8DA7F248EQ35746643-3D83CDD6-6D1C-4A75-8139-DF50D13E4555Q35900651-EA64624D-0596-4CEC-8ACA-54E0686BFD44Q36364326-03821F05-161A-4C16-9C2A-550AD852FE4EQ36366024-61D2DC5F-77C9-48C7-A8FC-50DE330C7534Q36547247-61B51820-E159-41E5-93BB-C289BCA7EF2CQ37512995-AEB1B1B0-5228-4AA0-9766-86E93CD53C98Q37990887-42631F18-0B25-4F7A-A305-92CE6EEAA2E1Q38110220-3111BDAF-3585-4A12-964E-91E66A33400FQ38454048-8A121378-B3F6-4769-ADC9-FC35917D47C7Q39006632-A87CC3DF-0DA9-4442-8362-C1AFBEE88E41Q41561648-EFFF8A34-4BD7-4D89-A975-4130935DDA0EQ43735474-3EAA96F0-B2E0-49A5-953F-B247DE026EFBQ44467344-BCEAB353-19BE-4781-ADDC-B9B31E3D30DAQ44592559-B395E5E1-CA9C-479D-B9B2-0A09F8040FF9Q45987400-6C4F0372-BAC1-4B51-BD14-D0C80BC1BD05Q53308227-9017B9C3-79C3-4E29-AFE9-4E4A1A6F0F7FQ58775320-1A19C148-4BBE-4E99-BB82-05F9134E6877
P2860
Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options.
@ast
Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options.
@en
type
label
Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options.
@ast
Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options.
@en
prefLabel
Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options.
@ast
Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options.
@en
P2093
P1433
P1476
Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options.
@en
P2093
P304
P356
10.1016/S0090-4295(99)00230-7
P407
P577
1999-09-01T00:00:00Z